Paxlovid and Long COVID Paxlovid and Long COVID
A new VA study adds a third way of reducing Long COVID, no less important complications across multiple organ systems, and improved survival and avoidance of hospitalizations. It is the first such report.Medscape (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - November 8, 2022 Category: Drugs & Pharmacology Tags: Infectious Diseases Commentary Source Type: news
FDA Expands Vemlidy Use to Adolescents With Chronic HBV FDA Expands Vemlidy Use to Adolescents With Chronic HBV
The indication for the nucleoside analog reverse transcriptase inhibitor in children aged 12 years and older is based on safety and efficacy data from a placebo-controlled clinical trial.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - November 4, 2022 Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news
The Public Shouldn't Pay for Drugs Twice The Public Shouldn't Pay for Drugs Twice
Taxpayers foot the bill for medical research, but companies profit. For equitable drug access, we need a new R&D model.Undark (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - November 3, 2022 Category: Drugs & Pharmacology Tags: Public Health & Prevention Commentary Source Type: news
STEP TEENS: Semaglutide'Gives Hope' to Adolescents With Obesity STEP TEENS: Semaglutide'Gives Hope' to Adolescents With Obesity
The so-called ' gamechanger ' obesity injection, semaglutide, is trialed in teenagers with obesity and comes up trumps.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - November 3, 2022 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
FDA Rejects Bulevirtide for Hepatitis D FDA Rejects Bulevirtide for Hepatitis D
The FDA cited concerns over the production and delivery of bulevirtide, an investigational, first-in-class hepatitis delta virus entry-inhibitor that received conditional approved in Europe in 2020.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 31, 2022 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
How to Prevent a Feared Complication After Joint Replacement How to Prevent a Feared Complication After Joint Replacement
Prioritizing bone health before and after knee or hip arthroplasty may help patients avoid periprosthetic fractures.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 31, 2022 Category: Drugs & Pharmacology Tags: Family Medicine/Primary Care News Source Type: news
Drug Shortages Are on the Rise in France Drug Shortages Are on the Rise in France
The number of pharmacy supply disruptions lasting at least a week has almost doubled since the start of the year. One pharmacist fears that the situation will worsen.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 26, 2022 Category: Drugs & Pharmacology Tags: Pharmacist News Source Type: news
Stopping Levothyroxine in Subclinical Hypothyroidism Safe, Feasible Stopping Levothyroxine in Subclinical Hypothyroidism Safe, Feasible
Despite apparent lack of benefits, many still receive levothyroxine for subclinical hypothyroidism. Study helps fill a data gap on discontinuation.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 24, 2022 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
IBD Drugs'Prohibitively' Expensive for Medicare Patients IBD Drugs'Prohibitively' Expensive for Medicare Patients
Over their lifetime, Medicare patients with IBD can expect to shell out tens to hundreds of thousands of dollars in out-of-pocket costs for needed medications.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 24, 2022 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
AGA Releases Guidelines on Anti-Obesity Medications AGA Releases Guidelines on Anti-Obesity Medications
New AGA guidelines advise use of anti-obesity medications for weight loss.MDedge News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 21, 2022 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
Don't Be Afraid of Weight Gain With Hyperthyroid Treatment Don't Be Afraid of Weight Gain With Hyperthyroid Treatment
A large study shows highest weight gain risk is with thyroidectomy, and radioiodine therapy is linked to better survival.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 21, 2022 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
FDA Panel Recommends Withdrawal of Makena for Preterm Birth FDA Panel Recommends Withdrawal of Makena for Preterm Birth
The FDA has been seeking the withdrawal since 2020.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 19, 2022 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Source Type: news
Insulin Rationing Common,'Surprising' Even Among Privately Insured Insulin Rationing Common,'Surprising' Even Among Privately Insured
Nationwide data reveal that Americans with private insurance are more likely to ration insulin than those with public health insurance and the insulin-treated diabetes population overall.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 17, 2022 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
Opioids Leading Cause of Poisoning Deaths in Young Children Opioids Leading Cause of Poisoning Deaths in Young Children
As opioid poisoning deaths in young children have surged, strategies to prevent fatalities and reduce harm, including naloxone use, are increasingly important, experts say.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 12, 2022 Category: Drugs & Pharmacology Tags: Pediatrics News Source Type: news
EMA Issues Positive Opinion on the Safety of Filgotinib EMA Issues Positive Opinion on the Safety of Filgotinib
The EMA has issued a positive opinion of the type II variation application of the JAK1 inhibitor filgotinib, based on testicular function safety data from two phase 2 clinical trials.International Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 5, 2022 Category: Drugs & Pharmacology Tags: Rheumatology News Alert Source Type: news
